Wakai, Haruki
Abe, Natsumi
Tokuda, Touno
Yamanaka, Rika
Ebihara, Satoshi
Izumaru, Kensuke
Ishii, Daisuke
Hyodo, Toru
Yoshida, Kazunari
Article History
Received: 13 December 2021
Accepted: 27 October 2022
First Online: 14 November 2022
Declarations
:
: This study was approved by the ethics committee of Reiseikai Medical Corporation (July 2nd, 2021) and conducted in accordance with the Declaration of Helsinki and the ethical guidelines provided by the Ministry of Health, Labour and Welfare. As this study involved no invasion or intervention to patients and used only information such as medical information and residual samples, an opt-out was provided to disclose information, and an opportunity for refusal was assured. And, all participants gave consent to participate after having been informed about the nature and purpose of the study. This study is registered with the Clinical Trials Registry (UMIN000046281).
: Not applicable.
: The authors declare no conflicts of interest.